Calumet Specialty Products(CLMT)
$35.89+0.98 (+2.81%)
CLMT
Calumet Specialty Products financials statements
$35.89
At close:+0.98 (+2.81%)
Want to see CLMT full AI Analyst Report?
Calumet Specialty Products (CLMT) Ratios
406 Followers
Calumet Specialty Products Ratios
CLMT's free cash flow for Q3 2026 was $206.70M. For the 2026 fiscal year, CLMT's free cash flow was decreased by $-11.80M and operating cash flow was $218.50M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.02 | 0.89 | 0.71 | 0.61 | 0.70 |
| Quick Ratio | 0.56 | 0.40 | 0.32 | 0.24 | 0.34 |
| Cash Ratio | 0.15 | 0.04 | 0.01 | 0.03 | 0.04 |
| Solvency Ratio | 0.04 | -0.02 | 0.07 | -0.02 | -0.05 |
| Operating Cash Flow Ratio | 0.13 | -0.05 | -0.01 | 0.07 | -0.05 |
| Short-Term Operating Cash Flow Coverage | 0.70 | -0.70 | -0.06 | 0.42 | -0.24 |
| Net Current Asset Value | $ -2.32B | $ -2.46B | $ -2.20B | $ -2.21B | $ -1.88B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.91 | 0.86 | 0.80 | 0.69 | 0.83 |
| Debt-to-Equity Ratio | -3.36 | -3.33 | -4.46 | -3.54 | -4.52 |
| Debt-to-Capital Ratio | 1.42 | 1.43 | 1.29 | 1.39 | 1.28 |
| Long-Term Debt-to-Capital Ratio | 1.54 | 1.53 | 1.37 | 1.53 | 1.38 |
| Financial Leverage Ratio | -3.67 | -3.87 | -5.60 | -5.14 | -5.47 |
| Debt Service Coverage Ratio | 0.89 | 0.54 | 0.89 | 0.24 | 0.04 |
| Interest Coverage Ratio | 0.25 | 0.03 | 1.21 | 0.75 | -0.57 |
| Debt to Market Cap | 1.30 | 1.16 | 1.45 | 1.33 | 1.53 |
| Interest Debt Per Share | 30.83 | 31.39 | 30.12 | 26.03 | 24.14 |
| Net Debt to EBITDA | 9.79 | 14.20 | 5.22 | 17.78 | 110.21 |
| Profitability Margins | |||||
| Gross Profit Margin | 5.94% | 5.51% | 10.80% | 7.50% | 4.54% |
| EBIT Margin | 2.17% | 0.37% | 6.49% | 0.13% | -3.47% |
| EBITDA Margin | 5.76% | 3.93% | 10.00% | 2.23% | 0.50% |
| Operating Profit Margin | 1.31% | 0.19% | 6.39% | 2.81% | -2.72% |
| Pretax Profit Margin | -3.06% | -5.28% | 1.19% | -3.63% | -8.21% |
| Net Profit Margin | -0.82% | -5.30% | 1.15% | -3.62% | -8.10% |
| Continuous Operations Profit Margin | -0.82% | -5.30% | 1.15% | -3.70% | -8.26% |
| Net Income Per EBT | 26.74% | 100.36% | 96.78% | 99.94% | 98.57% |
| EBT Per EBIT | -233.21% | -2730.86% | 18.60% | -128.81% | 302.10% |
| Return on Assets (ROA) | -1.26% | -8.05% | 1.75% | -6.19% | -11.98% |
| Return on Equity (ROE) | 4.61% | 31.14% | -9.78% | 31.82% | 65.54% |
| Return on Capital Employed (ROCE) | 2.93% | 0.43% | 16.31% | 9.49% | -6.97% |
| Return on Invested Capital (ROIC) | 0.70% | 0.40% | 13.19% | 7.75% | -5.81% |
| Return on Tangible Assets | -1.33% | -8.66% | 1.89% | -6.71% | -13.40% |
| Earnings Yield | -1.96% | -12.13% | 3.36% | -12.68% | -24.45% |
| Efficiency Ratios | |||||
| Receivables Turnover | 17.79 | 15.06 | 14.61 | 17.55 | 12.44 |
| Payables Turnover | 13.82 | 12.34 | 11.58 | 9.81 | 9.98 |
| Inventory Turnover | 10.10 | 9.51 | 8.49 | 8.71 | 9.20 |
| Fixed Asset Turnover | 2.62 | 2.50 | 2.58 | 2.95 | 2.86 |
| Asset Turnover | 1.54 | 1.52 | 1.52 | 1.71 | 1.48 |
| Working Capital Turnover Ratio | -102.79 | -20.16 | -9.85 | -11.74 | -22.75 |
| Cash Conversion Cycle | 30.24 | 33.03 | 36.48 | 25.49 | 32.44 |
| Days of Sales Outstanding | 20.51 | 24.23 | 24.99 | 20.80 | 29.33 |
| Days of Inventory Outstanding | 36.13 | 38.38 | 43.01 | 41.91 | 39.67 |
| Days of Payables Outstanding | 26.40 | 29.58 | 31.52 | 37.22 | 36.56 |
| Operating Cycle | 56.64 | 62.61 | 67.99 | 62.71 | 69.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 1.26 | -0.56 | -0.19 | 1.27 | -0.56 |
| Free Cash Flow Per Share | 0.65 | -1.48 | -3.58 | -5.49 | -1.61 |
| Dividend Paid and CapEx Coverage Ratio | 2.08 | -0.60 | -0.05 | 0.19 | -0.53 |
| Capital Expenditure Coverage Ratio | 2.08 | -0.60 | -0.05 | 0.19 | -0.53 |
| Operating Cash Flow Coverage Ratio | 0.04 | -0.02 | -0.01 | 0.05 | -0.03 |
| Operating Cash Flow to Sales Ratio | 0.03 | -0.01 | -0.00 | 0.02 | -0.01 |
| Free Cash Flow Yield | 3.28% | -6.72% | -20.04% | -32.53% | -12.17% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -50.95 | -8.25 | 29.75 | -7.89 | -4.09 |
| Price-to-Sales (P/S) Ratio | 0.42 | 0.44 | 0.34 | 0.29 | 0.33 |
| Price-to-Book (P/B) Ratio | -2.35 | -2.57 | -2.91 | -2.51 | -2.68 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 30.46 | -14.87 | -4.99 | -3.07 | -8.22 |
| Price-to-Operating Cash Flow Ratio | 15.83 | -39.46 | -96.04 | 13.31 | -23.69 |
| Price-to-Earnings Growth (PEG) Ratio | 0.60 | 0.01 | -0.23 | 0.23 | -0.06 |
| Enterprise Value Multiple | 17.02 | 25.33 | 8.64 | 30.62 | 177.04 |
| Enterprise Value | 4.06B | 4.17B | 3.61B | 3.19B | 2.76B |
| EV to EBITDA | 17.02 | 25.33 | 8.64 | 30.62 | 177.04 |
| EV to Sales | 0.98 | 0.99 | 0.86 | 0.68 | 0.88 |
| EV to Free Cash Flow | 71.70 | -33.84 | -12.60 | -7.33 | -21.76 |
| EV to Operating Cash Flow | 37.26 | -89.78 | -242.51 | 31.74 | -62.77 |
| Tangible Book Value Per Share | -7.33 | -7.96 | -5.57 | -6.29 | -7.73 |
| Shareholders’ Equity Per Share | -8.45 | -8.57 | -6.14 | -6.73 | -4.92 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.73 | -0.00 | 0.03 | -0.02 | -0.01 |
| Revenue Per Share | 47.68 | 50.39 | 52.21 | 59.07 | 39.86 |
| Net Income Per Share | -0.39 | -2.67 | 0.60 | -2.14 | -3.23 |
| Tax Burden | 0.27 | 1.00 | 0.97 | 1.00 | 0.99 |
| Interest Burden | -1.41 | -14.27 | 0.18 | -28.32 | 2.37 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.04 | 0.05 | 0.03 | 0.03 | 0.05 |
| Stock-Based Compensation to Revenue | -0.00 | 0.00 | 0.00 | 0.00 | 0.02 |
| Income Quality | -3.22 | 0.21 | -0.31 | -0.59 | 0.17 |
Currency in USD
